Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population

  1. Ariel Israel  Is a corresponding author
  2. Alejandro A Schäffer
  3. Assi Cicurel
  4. Ilan Feldhamer
  5. Ameer Tal
  6. Kuoyuan Cheng
  7. Sanju Sinha
  8. Eyal Schiff
  9. Gil Lavie
  10. Eytan Ruppin  Is a corresponding author
  1. Clalit Health Services, Israel
  2. National Institutes of Health, United States
  3. Sheba Medical Center, Israel
  4. Tel-Aviv University, Israel

Peer review process

This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.

History

  1. Version of Record published
  2. Accepted Manuscript published
  3. Accepted
  4. Received
  5. Preprint posted

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ariel Israel
  2. Alejandro A Schäffer
  3. Assi Cicurel
  4. Ilan Feldhamer
  5. Ameer Tal
  6. Kuoyuan Cheng
  7. Sanju Sinha
  8. Eyal Schiff
  9. Gil Lavie
  10. Eytan Ruppin
(2021)
Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population
eLife 10:e68165.
https://doi.org/10.7554/eLife.68165

Share this article

https://doi.org/10.7554/eLife.68165